Clinical Trial Update: Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of tegaserod in male patients with chronic constipation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• Tegaserod (Zelnorm) (tegaserod)

Snippet

Sponsor: Novartis | Conditions: Chronic Constipation | Phase 3 | Status: COMPLETED